Atea Pharmaceuticals (AVIR) Operating Margin (2021)
Atea Pharmaceuticals (AVIR) has 1 years of Operating Margin data on record, last reported at 63.06% in Q4 2021.
- For Q4 2021, Operating Margin changed N/A year-over-year to 63.06%; the TTM value through Sep 2022 reached 15.83%, down 794.0%, while the annual FY2021 figure was 39.38%, 6206.0% up from the prior year.
- Operating Margin reached 63.06% in Q4 2021 per AVIR's latest filing, up from 67.5% in the prior quarter.
- Across five years, Operating Margin topped out at 63.06% in Q4 2021 and bottomed at 67.5% in Q3 2021.